Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-15T05:10:52.760Z Has data issue: false hasContentIssue false

Chapter 9 - Antineuropathic Medications

from Part II - Common Categories of Pharmacologic Medications to Treat Chronic Pain

Published online by Cambridge University Press:  01 December 2023

By
Juyeon Kakazu  and
Alan D. Kaye
Edited by
Omar Viswanath  and
Ivan Urits
Omar Viswanath
Affiliation:
Creighton University, Omaha
Ivan Urits
Affiliation:
Southcoast Brain & Spine Center, Wareham
Get access

Summary

Neuropathic pain (NP) is a subtype of chronic pain syndrome defined by International Association of the Study of Pain (IASP) as a “pain caused by a lesion or disease of the somatosensory system.” Consequence of CNS or PNS lesions are activities generated in the somatosensory system without peripheral afferent stimulation. The pathophysiology of the somatosensory system is injury causing complex ectopic signaling between neuronal pathways. There are several types of antineuropathic medications that are currently utilized to treat this subtype of pain, including gabapentin, pregabalin, and duloxetine, amongst others.

Keywords

antineuropathicnerve painantidepressantsantiepilepticsgabapentinpregabalin
Type
Chapter
Information
Cambridge Handbook of Pain Medicine , pp. 61 - 65
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jensen, TS, Baron, R, Haanpää, M et al. A new definition of neuropathic pain. Pain. 2011;152(10):2204–2205. https://doi.org/10.1016/J.PAIN.2011.06.017.CrossRefGoogle ScholarPubMed
Jones, MR, Urits, I, Wolf, J et al. Drug-induced peripheral neuropathy: A narrative review. Current Clinical Pharmacology. 2020;15(1):38–48. https://doi.org/10.2174/1574884714666190121154813.Google ScholarPubMed
Gierthmühlen, J, Baron, R. Neuropathic pain. Seminars in Neurology. 2016;36(5):462–468. https://doi.org/10.1055/S-0036-1584950.Google ScholarPubMed
Bennett, MI, Rayment, C, Hjermstad, M et al. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain. 2012;153(2):359–365. https://doi.org/10.1016/J.PAIN.2011.10.028.CrossRefGoogle ScholarPubMed
Hébert, HL, Veluchamy, A, Torrance, N, Smith, BH. Risk factors for neuropathic pain in diabetes mellitus. Pain. 2017;158(4):560. https://doi.org/10.1097/J.PAIN.0000000000000785.CrossRefGoogle ScholarPubMed
Davis, MP. Cancer-related neuropathic pain: Review and selective topics. Hematology/Oncology Clinics of North America. 2018;32(3):417–431. https://doi.org/10.1016/J.HOC.2018.01.005.CrossRefGoogle ScholarPubMed
Howard, RF, Wiener, S, Walker, SM. Neuropathic pain in children. Archives of Disease in Childhood. 2014;99(1):84–89. https://doi.org/10.1136/ARCHDISCHILD-2013-304208.CrossRefGoogle ScholarPubMed
Tınastepe N, Oral K. Neuropathic pain after dental treatment. Agri: Agri (Algoloji) Dernegi’nin Yayin organidir = The Journal of the Turkish Society of Algology. 2013;25(1):1–6. https://doi.org/10.5505/AGRI.2013.55477.Google Scholar
Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nature Neuroscience. 2007;10(11):1361–1368. https://doi.org/10.1038/NN1992.CrossRefGoogle ScholarPubMed
Fornasari, D. Pharmacotherapy for neuropathic pain: A review. Pain and Therapy. 2017;6(Suppl 1):25. https://doi.org/10.1007/S40122-017-0091-4.CrossRefGoogle ScholarPubMed
Zilliox, LA. Neuropathic pain. Continuum (Minneapolis, Minn). 2017;23(2):512–532. https://doi.org/10.1212/CON.0000000000000462.Google ScholarPubMed
Cruccu, G, Truini, A. A review of neuropathic pain: From guidelines to clinical practice. Pain Ther. 2017;6(Suppl 1):35. https://doi.org/10.1007/S40122-017-0087-0.CrossRefGoogle ScholarPubMed
Pregabalin (Oral Route) Side Effects – Mayo Clinic. 2023. Accessed October 13, 2021. www.mayoclinic.org/drugs-supplements/pregabalin-oral-route/side-effects/drg-20067411?p=1.Google Scholar
Side Effects – Antidepressants – NHS. 2021. Accessed October 13, 2021. www.nhs.uk/mental-health/talking-therapies-medicine-treatments/medicines-and-psychiatry/antidepressants/side-effects/.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×